Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma.

MLA

Attalla, Kyrollis, et al. “Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 27, no. 20, Oct. 2021, pp. 5595–606. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-20-4058.

APA

Attalla, K., DiNatale, R. G., Rappold, P. M., Fong, C. J., Sanchez-Vega, F., Silagy, A. W., Weng, S., Coleman, J., Lee, C.-H., Carlo, M. I., Durack, J. C., Solomon, S. B., Reuter, V. E., Russo, P., Chan, T. A., Motzer, R. J., Schultz, N. D., Reznik, E., Voss, M. H., & Hakimi, A. A. (2021). Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 27(20), 5595–5606. https://doi.org/10.1158/1078-0432.CCR-20-4058

Chicago

Attalla, Kyrollis, Renzo G DiNatale, Phillip M Rappold, Christopher J Fong, Francisco Sanchez-Vega, Andrew W Silagy, Stanley Weng, et al. 2021. “Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 27 (20): 5595–5606. doi:10.1158/1078-0432.CCR-20-4058.